Literature DB >> 6261269

Correlation between the dose and development of acute tolerance to the hypothermic effect of THC.

B Uran, F C Tulunay, I H Ayhan, E Ulkü, S Kaymakçalan.   

Abstract

The administration of 0.3-40 mg/kg delta 9-tetrahydrocannabinol (THC) produced a dose-dependent hypothermia in rats. The maximal hypothermic effect was obtained with the dose of 2.5 mg/kg of THC. When the same doses of THC were repeated on days 2 and 3, tolerance to the hypothermic effect of THC was apparent. Doses of THC higher than 2.5 mg/kg induced a significant and dose-dependent tolerance after the first administration whereas with the lower doses, tolerance was only apparent after the second injection. The possible mechanism of these effects of THC is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6261269     DOI: 10.1159/000137458

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.

Authors:  F C Tulunay; I H Ayhan; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

Authors:  Michael S Smirnov; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2008-06-26       Impact factor: 3.252

3.  Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure.

Authors:  Brett C Ginsburg; Lenka Hruba; Armia Zaki; Martin A Javors; Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

4.  A Model of Combined Exposure to Nicotine and Tetrahydrocannabinol via Electronic Cigarettes in Pregnant Rats.

Authors:  Kristen R Breit; Cristina G Rodriguez; Samirah Hussain; Karen J Thomas; Mikayla Zeigler; Ioanna Gerasimidis; Jennifer D Thomas
Journal:  Front Neurosci       Date:  2022-03-16       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.